Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus cream under occlusion in atopic dermatitis
NCT00925730Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2004
- Primary completion
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pimecrolimus in atopic dermatitis (AD), sponsored by Novartis. Primary endpoint: Pimecrolimus blood concentration at Day 16. Started Mar 2004; status: completed.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00925730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925730.